carbowemb 150mg\15ml injection
Prescription Required
Marketed By
Wembrace Biopharma pvt. Ltd.
Pack of
1 vial(s)
Salt Composition
Carboplatin Injection
Storage
keep store in cold place
₹730₹930.02
21.51% Off
Inclusive of all taxes
1
carbowemb 150mg\15ml injection
Delivering To: —
All Substitutes
Indication
Chemotherapy drugs, Ovaries Cancer, Lung cancer
Description
Carbowemb 150mg\15ml injection is an anti neoplastic medication. It is used in the treatment of Ovarian Cancers and Small-Cell Lung Cancer. Carbowemb 150mg\15ml injection contains Carboplatin as its active ingredient that work against the cancer.
Common Side Effects
The side effects of Carbowemb 150mg\15ml injection can vary from mild to extreme, affecting different parts of the body. Consult your doctor if symptoms persist for longer period of time.
● Weakness
● Anemia
● Low White Blood Cell Count
● Nausea
● Low Platelet Count
● Mouth Sores
● Irritation
● Burning Sensation
● Numbness
● Tingling in Hands
● Serious Infections
● Allergic Reactions
● Kidney Damage or Failure
● Severe Bleeding or Hemorrhage
● Neuro toxicity
● Hearing loss
● Serious Electrolyte Balance
Dosage And Administration
Carbowemb 150mg\15ml injection dosage may vary based on the type of cancer being treated, the kidney's function and overall health status. The exact dosing is individualised. Dosing cycle repeats every 3-4 weeks to allow recovery from side effects. Carbowemb 150mg\15ml injection is administered intravenously slowly over 15-60 minutes. Consult your doctor for exact dosage and treatment schedule.
Mechanism Of Action
Carbowemb 150mg\15ml injection contains Carboplatin as its active ingredient that work against the cancer. It mainly works by binding to DNA of cancer cell, disrupting their genetic structure.Therefore, preventing its further growth and proliferation in the body, ultimately leading to cell death.
Safety Advice
Alcohol
consult your doctor
Alcohol consumption tends to reduce effectiveness of Carbowemb 150mg injection. Therefore, it is not recommended to drink during this injection course. Consult your doctor for more details.
Driving
consult your doctor
Carbowemb 150mg\15ml injection administration lead to diziness that can affect the patient's ability to drive. Therefore, it is not recommended to drive. Consult your doctor for more information.
Pregnancy
consult your doctor
Carbowemb injection cause significant direct harm to the growing baby ,Thats why it is not recommended. Talk to your doctor for detailed information.
Breast Feeding
consult your doctor
At the time of the Carbowemb 15ml injection course, breastfeeding is not permitted. Consult your doctor for safe alternatives.
Kidney
caution
Share your medical history details related to kidney cancer or any other disease with your doctor before taking Carbowemb 150mg\15ml injection. As it may weaken the kidney.
Liver
caution
Inform your doctor about any liver disease or infection before starting Carbowemb injection course.As It can lead to severe liver problems.
Faqs
Carbowemb 150mg\15ml injection majorly treats Ovarian Cancer as well as Small Cell Lung Cancer.
Carbowemb 15ml injection contains Carboplatin as its active ingredient.
Carbowemb injection contain Carboplatin as its active ingredient. It distorts DNA structure, inhibiting replication and transcription, activating repair pathways that fail, and triggering apoptosis or necrosis in rapidly dividing cancer cells.
No do not self administer the Carbowemb injection . As wrong administration can lead to severe side effects as well as reduce effectiveness of the medication.
Yes, there are serious side effects of Carbowemb 15ml injection such as Severe allergic reactions (rash, hives, swelling), Bone marrow suppression (increased infection and bleeding risk), Pneumonia, sepsis, other severe infections, Anemia causing fatigue and complications, Neurological issues: speech or coordination problems, Kidney problems etc.
References
• BUCKINGHAM, R., FITT, J., & SITZIAZ, J. (1997). Patients' experiences of chemotherapy: side‐effects of carboplatin in the treatment of carcinoma of the ovary. European journal of cancer care, 6(1), 59-71.
• Oun, R., Moussa, Y. E., & Wheate, N. J. (2018). The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton transactions, 47(19), 6645-6653.
• Yarbro, C. H. (1989, May). Carboplatin: A clinical review. In Seminars in oncology nursing (Vol. 5, No. 2, pp. 63-69). WB Saunders.
• Wagstaff, A. J., Ward, A., Benfield, P., & Heel, R. C. (1989). Carboplatin: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs, 37(2), 162-190.
Related Products
MARKETER DETAILS
Wembrace Biopharma pvt. Ltd.
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.